Peter Nowell and David Hungerford in 1960

Chronic Myeloid Leukemia (CML) is not a cancer you hear about very often. That’s not because it isn’t serious — until recently, it carried a frightening prognoses. Until about 2000, newly diagnosed CML patients had a 5-year survival rate of 31%. But we don’t hear much about CML because it is a rare disease, and affects far fewer people than cancers of the breast or prostate, or lung cancer.… Read the rest “Chronic Myeloid Leukemia: a Molecular Diagnosis”